As we previously showed that LUBAC acts as a gatekeeper for cell death induction by TNF, FasL and TRAIL, independently of NF-κB regulation [36, 59, 60], we next examined whether LUBAC deficiency could sensitize cancer cells to death induced by LTβR activation. Here, FASLG is linked to cancer.